Comparison Chart Kymera Therapeutics, Inc.

Equities

KYMR

US5015751044

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 14:35:18 15/05/2026 BST			5-day change	1st Jan Change
83.24 ^USD	-1.49%		-0.15%	+8.60%

12:14pm	Kymera Therapeutics announces presentations on KT-621, a first-in-class, oral Stat6 degrader, at the Society for Investigative Dermatology and American Thoracic Society congresses	RE
05-12	Kymera Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09:20 AM

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	KYMERA THERAPEUTICS, INC.	Other Biotechnology & Medical Research	-1.27%	-0.15%	+8.60%	+184.03%	+85.63%	6.95B